HEALTH OF WOMAN. 2019.2(138): 14–18; doi 10.15574/HW.2019.138.14

Бурка О. А. , Тутченко Т. Н.
Национальный медицинский университет имени А.А. Богомольца, г. Киев
ГУ «Институт педиатрии, акушерства и гинекологии имени академика А.Н. Лукьяновой НАМНУ », г. Киев
МЛ ДИЛА., Г. Киев

Учитывая существенные изменения в подходах к профилактике рака шейки матки (РШМ), которые происходят в течение последних десятилетий, в статье рассмотрено понятие первичного, вторичного и третичного уровней профилактических мероприятий по онкологической патологии в общем, сущности и цели скрининговых исследований, требованиям к диагностическим тестам, которые могут использоваться в качестве скрининговых.

Подробно освещены современные подходы к цервикальному скринингу как ключевой составляющей вторичной профилактики РШМ, особенностям существующих скрининговых программ, основанных на первичном определении высокоонкогенных штаммов вируса папилломы человека изолированно и в сочетании с цитологическим исследованием.

Ключевые слова: рак шейки матки, дисплазия, цервикальная интраэпителиальная неоплазия, вирус папилломы человека, скрининг.

СПИСОК ЛИТЕРАТУРЫ

1. Vu M., Yu J., Awolude O.A., & Chuang L. (2018). Cervical cancer worldwide. Current problems in cancer. https://doi.org/10.1016/j.currproblcancer.2018.06.003; PMid:30064936

2. Жилка Н.Я. та Т.В. Зайкова. Сучасні підходи до профілактики раку шийки матки // Україна. Здоров’я нації. 4 (2014): 53–56.

3. Hall M.T., Simms K.T., Lew J.B., Smith M.A., Brotherton J.M., Saville M., … & Canfell K. (2019). The projected timeframe until cervical cancer elimination in Australia: a modelling study. The Lancet Public Health, 4(1), e19-e27. https://doi.org/10.1016/S2468-2667(18)30183-X

4. Alder, Susanna. Prevention of cervical cancer in countries with high and low incidence of the disease. Inst för kvinnors och barns hälsa/Dept of Women’s and Children’s Health, 2018.

5. Forman D., Bauld L., Bonanni B., Brenner H., Brown K., Dillner J., … & Storm H. (2018). Time for a European initiative for research to prevent cancer: a manifesto for Cancer Prevention Europe (CPE). Journal of cancer policy. https://doi.org/10.1016/j.jcpo.2018.07.001

6. P. Basu, A. Ponti, A. Anttila, et al. Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report, Int. J. Cancer 142 (1) (2018) 44–56. https://doi.org/10.1002/ijc.31043; PMid:28940326

7. H. Brenner, C. Stock, M. Hoffmeister, Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies, BMJ 348 (2014) g2467. https://doi.org/10.1136/bmj.g2467; PMid:24922745 PMCid:PMC3980789

8. Brotherton J.M., & Bloem P.N. (2018). Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage. Best practice & research Clinical obstetrics & gynaecology, 47, 42–58. https://doi.org/10.1016/j.bpobgyn.2017.08.010; PMid:28986092

9. Association between Bacterial Vaginosis and Cervical Intraepithelial Neoplasia: Systematic Review and Meta-Analysis.2012.

10. Karim S., Souho T., Benlemlih M., & Bennani  B. (2018). Cervical cancer induction enhancement potential of Chlamydia trachomatis: A systematic review. Current microbiology, 75(12), 1667–1674. https://doi.org/10.1007/s00284-018-1439-7; PMid:29356877

11. IARC. IARC handbooks of cancer prevention. Vol. 10. Cervix cancer screening.Lyon, France: IARC; 2005.

12. National Cancer Institute; Chasan R, Manrow R. Cervical cancer. https://report.nih.gov/nihfactsheets/ viewfactsheet.aspx?csid=76. Accessed February 14, 2019.

13. Munoz N., Castellsagué X., de González A.B., & Gissmann L. (2006). HPV in the etiology of human cancer. Vaccine, 24, S1–S10. https://doi.org/10.1016/j.vaccine.2006.05.115; PMid:16949995

14. Holland W., S. Stewart, and C. Masseria. Основы политики. Скрининг в Европе. No. EUR/05/5065809. Всемирная организация здравоохранения. Европейское региональное бюро, 2006.

15. https://www.who.int/cancer/detection/cervical_cancer_screening/en/

16. Pimple S., Mishra G., & Shastri S. (2016). Global strategies for cervical cancer prevention. Current Opinion in Obstetrics and Gynecology, 28(1), 4–10. https://doi.org/10.1097/GCO.0000000000000241; PMid:26642063

17. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 99: management of abnormal cervical cytology and histology. Obstet Gynecol. 2008;112:1419–1444. https://doi.org/10.1097/AOG.0b013e318192497c; PMid:19037054

18. Hartmann K, Hall SA, Nanda K, et al. Systematic Evidence Review Number 25: Screening for Cervical Cancer. Rockville, MD: US Department of Health and Human Services. http://www.ahrq.gov/downloads/pub/prevent/pdfser/cervcanser.pdf. Accessed February 10, 2011.

19. Gibb, Randall K., and Mark G. Martens. «The impact of liquid-based cytology in decreasing the incidence of cervical cancer». Reviews in Obstetrics and Gynecology 4.Suppl 1 (2011): S2.

20. Díaz-Rosario LA, Kabawat SE. Performance of a fluid-based, thin-layer Papanicolaou smear method in the clinical setting of an independent laboratory and an outpatient screening population in New England. Arch Pathol Lab Med.1999;123:817–821.

21. Sasieni P, Castanon A. NHSCSP Audit of Invasive Cervical Cancer:National Report 2009-2013. http://www.wolfson.qmul.ac.uk/images/pdfs/nhscsp-audit-invasive-cervical-cancer-Feb_2014.pdf

22. Castanon A, Landy R, Sasieni P. By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?J Med Screen 2017;24:110–2. https://doi.org/10.1177/0969141316654197; PMid:27363972 PMCid:PMC5490776

23. Melnikow J., Henderson J.T., Burda B.U., Senger C.A., Durbin S., & Weyrich M.S. (2018). Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US Preventive Services Task Force. Jama, 320(7), 687–705. https://doi.org/10.1001/jama.2018.10400; PMid:30140883

24. Melnikow J., Henderson J.T., Burda B.U., Senger C.A., Durbin S., & Weyrich M.S. (2018). Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US Preventive Services Task Force. Jama, 320(7), 687–705. https://doi.org/10.1001/jama.2018.10400; PMid:30140883

25. Schiffman M., Kinney W.K., Cheung L.C., Gage J.C., Fetterman B., Poitras N.E., … & Katki H.A. (2017). Relative performance of HPV and cytology components of cotesting in cervical screening. JNCI: Journal of the National Cancer Institute, 110(5), 501–508. https://doi.org/10.1093/jnci/djx225; PMid:29145648 PMCid:PMC6279277

26. Castle P., Feldman S., & Perkins R.B. (2018). The Next Generation of Cervical Cancer Screening: Should Guidelines Focus on Best Practices for the Future or Current Screening Capacity?. Journal of lower genital tract disease, 22(2), 91. https://doi.org/10.1097/LGT.0000000000000378; PMid:29570563 PMCid:PMC5895142

27. The American College of Obstetricians and Gynecologists (ACOG). Frequently asked questions. Cervical cancer screening. www.acog. org/Patients/FAQs/Cervical-Cancer-Screening. Accessed February 14, 2019.

28. Saslow D, Solomon D, Lawson HW, et al; American Cancer Society; American Society for Colposcopy and Cervical Pathology; American Society for Clinical Pathology. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012; 137(4):516–542. https://doi.org/10.1309/AJCPTGD94EVRSJCG; PMid:22431528

29. US Preventive Services Task Force; Curry SJ, Krist AH, Owens DK, et al. Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2018; 320(7):674–686. https://doi.org/10.1001/jama.2018.10897; PMid:30140884

30. Salina Zhang B.S., Batur  P., & NCMP, C. (2019). Human papillomavirus in 2019: An update on cervical cancer prevention and screening guidelines. Cleveland Clinic journal of medicine, 86(3), 173. https://doi.org/10.3949/ccjm.86a.18018; PMid:30849035